{"paper_id":"f791cb28-edcb-44a1-8cbd-18dbf7b2df57","body_text":"Association of Residential Factors and Platelet-to-Lymphocyte Ratio with Uterine Leiomyoma Occurrence\nDOI:\nhttps://doi.org/10.35870/ljit.v4i2.8755Keywords:\nleiomyoma; Residential; Urban-rural; Platelet-to-Lymphocyte Ratio; inflammationAbstract\nUterine leiomyoma is the most common benign gynecological tumor and is influenced by various individual, environmental, and inflammatory factors. Residential environmental characteristics and the Platelet-to-Lymphocyte Ratio (PLR) have been proposed as potential factors associated with leiomyoma occurrence. This study aimed to analyze the association between residential factors and PLR with the occurrence of uterine leiomyoma. This study used an observational analytic design with a case-control approach. The study included 256 histopathological medical records from 2020-2023, consisting of 185 patients with uterine leiomyoma as the case group and 71 patients with adenomyosis as the control group. Residential characteristics were classified into urban and rural areas based on the Central Bureau of Statistics (BPS) classification. PLR was calculated by dividing the absolute platelet count by the absolute lymphocyte count, with a cut-off value of 216.86 based on the 75th percentile. Bivariate analysis was performed using the Chi-Square test or Fisher’s Exact Test. Ethical clearance from the Health Research Ethics Committee of PKU Muhammadiyah Hospital, Surakarta, under number 08/KEPK/RS.PKU/IX/2025. Most respondents in both groups lived in urban areas, accounting for 93.51% of the leiomyoma group and 91.55% of the adenomyosis group. No significant association was found between residential area and uterine leiomyoma occurrence (p=0.590). Similarly, PLR was not significantly associated with uterine leiomyoma occurrence (p=0.878). Residential factors and PLR were not significantly associated with the occurrence of uterine leiomyoma in this study.\nDownloads\nReferences\nAgnes, Y., Djuda, C., Sari, P., Wahyuni, R. D., Fery, I. P., & White, I. (2024). Hubungan Neutrophil-Lymphocyte Ratio ( NLR ) terhadap Ukuran Massa Tumor dan Anemia pada Kejadian Mioma Uteri The Relationship of Neutrophil-Lymphocyte Ratio ( NLR ) To Tumor Mass Size and Anemia of Uterine Myoma Occurrence . 6(2), 63-72.\nAnjos, L. G., de Almeida, B. C., Baracat, E. C., Al-Hendy, A., Yang, Q., & Carvalho, K. C. (2023). Gene Expression Profile of Uterine Leiomyoma from Women Exposed to Different Air Pollution Levels in Metropolitan Cities of Sao Paulo, Brazil. International Journal of Molecular Sciences, 24(3). https://doi.org/10.3390/ijms24032431\nBadan Pusat Statistik. (2021). Peraturan Badan Pusat Statistik Nomor 120 Tahun 2020 tentang klasifikasi desa perkotaan dan perdesaan di Indonesia tahun 2020. https://www.bps.go.id/id/publication/2021/05/26/cff43de20a058e9e8400ca57/peraturan-kepala-badan-pusat-statistik-nomor-120-tahun-2020-tentang-klasifikasi-desa-perkotaan-dan-perdesaan-di-indonesia-2020-buku-2-jawa.html\nBrissett, E., & Theses, C. M. C. S. (2025). Scholarship @ Claremont Investigating the Impact of Phthalate Exposures from Personal Care Products on Uterine Fibroid Occurrence and Prevalence In US- Born Black Women Investigating the Impact of Phthalate Exposures from Personal Care Products on Uterine.\nBusch, E. L. (2021). Cut points and contexts. Cancer, 127(23), 4348-4355. https://doi.org/10.1002/cncr.33838\nChen, Y., Guo, X., Wu, J., Weng, R., Wang, X., Liu, Y., Wang, X., & Liu, H. (2025). Association between combined exposure to organochlorine pesticides and history of uterine fibroids in NHANES: findings from four statistical models. BMC Public Health. https://doi.org/10.1186/s12889-025-22274-6\nCho, Y. H., Yoon, Y. S., Koo, M. S., Kim, W., Kho, Y., Kim, S., Kim, Y. J., Choi, H., Choi, E. J., Koh, J. W., Chun, K. C., & Kim, Y. A. (2021). Exposure to phthalates and alternative plasticizers is associated with Methylation changes of esr1 and PGR in uterine Leiomyoma: The ELENA study. Applied Sciences (Switzerland), 11(9), 1-12. https://doi.org/10.3390/app11094234\nDong, Y., Chen, Y. H., Wang, Y. N., Wang, L., Zhou, Y., Xue, M., & Sun, L. (2024). Correlation between the systemic immunoinflammatory index and platelet-lymphocyte ratio in patients with adenomyosis. Mediators of Inflammation, 2024. https://doi.org/10.1155/2024/9977750\nDuan, Y., Guo, L., Peng, Y., Shi, X., Zhao, Y., Liu, K., Zhou, R., Fu, J., & Peng, C. (2023). Correlation between inflammatory marker and lipid metabolism in patients with uterine leiomyomas. Frontiers in Medicine, 10(May), 1-9. https://doi.org/10.3389/fmed.2023.1124697\nFarma, A. F. F., & Kurniati, Y. P. (2024). Analysis of The Occurrence of Uterine Leiomyoma Based on Body Mass Index and Neutrophil-Lymphocyte Ratio. 05(05), 998-1007. https://doi.org/10.37899/journallamedihealtico.v5i5.1609\nJeong, Y. Y., Lee, E. J., Cho, E. B., Ryu, J. M., & Choi, Y. S. (2021). The role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio as a supplemental tool for differential diagnosis of uterine myoma and sarcoma. Clinical and Experimental Obstetrics and Gynecology, 48(4), 901-906. https://doi.org/10.31083/j.ceog4804142\nJing, X., Li, C., Sun, J., Peng, J., Dou, Y., Xu, X., Ma, C., Dong, Z., Liu, Y., Zhang, H., Shao, Q., Zhang, H., Wang, L., Zhang, Y., & Qu, X. (2020). Systemic inflammatory response markers associated with infertility and endometrioma or uterine leiomyoma in endometriosis. Therapeutics and Clinical Risk Management, 16, 403-412. https://doi.org/10.2147/TCRM.S232849\nKaushansky, K., Lichtman, M. A., Prchal, J. T., Levi, M., Press, O. W., Burns, L. J., & Caligiuri, M. A. (2021). William’s hematology (10th ed.). McGraw Hill.\nKurniati, Y. P., Romadhon, Y. A., & Parawansa, K. I. P. (2024). Analysis of Adenomyosis Occurrence based on Age and Neutrophil-lymphocyte Ratio Factors. JHeS (Journal of Health Studies), 8(1), 37-45. https://doi.org/10.31101/jhes.3536\nLiu, M., Gou, Y., & Yang, P. (2025). Association between preoperative neutrophil-to-lymphocyte ratio and length of stay in pediatric patients undergoing laparoscopic appendectomy: a retrospective cohort study. BMC Pediatrics, 25(1). https://doi.org/10.1186/s12887-025-06043-3\nLizuka, T., Yin, P., Zuberi, A., Kujawa, S., & V, J. S. C. (2022). leiomyoma cell survival through tryptophan-kynurenine-AHR pathway activation. 1-11. https://doi.org/10.1073/pnas.2208886119/-/DCSupplemental.Published\nMaharizdihar, E. F., & Kurniati, Y. P. (2025). The Role of Menarcheal Age and Parity in the Development of Uterine Leiomyoma. 4(03), 144-154. https://doi.org/10.56741/hesmed.v4i03.1415\nMitro, S. D., Dyer, W., Lee, C., Bindra, A., Wang, L., Ritterman Weintraub, M., Hedderson, M. M., & Zaritsky, E. (2025). Uterine Fibroid Diagnosis by Race and Ethnicity in an Integrated Health Care System. JAMA Network Open, 8(4), 1-12. https://doi.org/10.1001/jamanetworkopen.2025.5235\nMukherjee, P. (2025). Genetic and biomarker approaches to uterine fibroids: toward precision medicine. Frontiers in Global Women’s Health, 6(April). https://doi.org/10.3389/fgwh.2025.1581823\nMutmainnah, U., Marselina, Dilla Srikandi, S., & Ummu, A. (2023). Faktor Risiko Kejadian Mioma Uteri Pada Pasien Rawat Jalan di RSUD Undata Provinsi Sulawesi Tengah. 7(2), 245-259.\nParamarta, N. P. T., & Kurniati, Y. P. (2025). Analysis of age factor and hemoglobin profiles in the occurrence of uterine leiomyoma. Jurnal Kesehatan, 16(3), 384-392. https://doi.org/10.26630/jk.v16i3.5393\nPrasetyo, A., Nuraini, N., Rachmawati, E., & Vestine, V. (2025). Faktor Risiko Leiomyoma Uterus di Rumah Sakit Umum Pusat Dr. Kariadi Semarang. 6(4), 265-275. https://doi.org/10.25047/j-remi.v6i4.6009\nRidwan, M., Lestari, G. I., & Fibrila, F. (2021). Kontrasepsi Hormonal dengan Kejadian Mioma Uteri Relationship of Maternal Age, Obesity and Hormonal Contraceptive Use with Occurrence of Uterine Myoma. 8, 11-22.\nSeptiawati, D., Kunusa, W. R., Mohamad, Erni, S. A. M., Soetijon, Kurniawan, I., Firdaus, Tangio, J. S., Iswahyudi, D. S. A. N. R. K. T., Sari, N. K., & Budiharto, T. (2021). Kesehatan Lingkungan Pemukiman dan Perkotaan (Vol. 32, Issue 3).\nSuh, D. S., Song, Y. J., Roh, H. J., Lee, S. H., Jeong, D. H., Lee, T. H., Choi, K. U., & Kim, K. H. (2021). Preoperative blood inflammatory markers for the differentiation of uterine leiomyosarcoma from leiomyoma. Cancer Management and Research, 13, 5001-5011. https://doi.org/10.2147/CMAR.S314219\nSyarifah, L. M., Dwi, P., Trihono, & Razak, T. (2023). Survei Kesehatan Indonesia (SKI).\nWesselink, A. K., Henn, B. C., Fruh, V., Geller, R. J., Coleman, C. M., Schildroth, S., Sjodin, A., Bethea, T. N., Noel, N. L., Baird, D. D., Wegienka, G., & Wise, L. A. (2025). Persistent endocrine-disrupting chemicals and incident uterine leiomyomata: a mixtures analysis. https://doi.org/10.1016/j.scitotenv.2024.175871.Persistent\nZannotti, A., Greco, S., Pellegrino, P., Giantomassi, F., Carpini, G. D., Goteri, G., Ciavattini, A., & Ciarmela, P. (2021). Macrophages and immune responses in uterine fibroids. Cells, 10(5). https://doi.org/10.3390/cells10050982\nZhang, H., Zhou, H., Chen, X., Guo, H., Lin, Q., & Chen, X. (2024). Phthalate exposure as a hidden risk factor for uterine leiomyoma in adult women: Accumulated evidence from observational studies. Ecotoxicology and Environmental Safety, 285(September), 117069. https://doi.org/10.1016/j.ecoenv.2024.117069\nDownloads\nPublished\nIssue\nSection\nLicense\nCopyright (c) 2026 Megananda Valeda Send, Yuni Prastyo Kurniati\nThis work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.\nAuthors who publish with this journal agree to the following terms:\n1. Copyright Retention and Open Access License\nAuthors retain copyright of their work and grant the journal non-exclusive right of first publication under the Creative Commons Attribution 4.0 International License (CC BY 4.0).\nThis license allows unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.\n2. Rights Granted Under CC BY 4.0\nUnder this license, readers are free to:\n- Share — copy and redistribute the material in any medium or format\n- Adapt — remix, transform, and build upon the material for any purpose, including commercial use\n- No additional restrictions — the licensor cannot revoke these freedoms as long as license terms are followed\n3. Attribution Requirements\nAll uses must include:\n- Proper citation of the original work\n- Link to the Creative Commons license\n- Indication if changes were made to the original work\n- No suggestion that the licensor endorses the user or their use\n4. Additional Distribution Rights\nAuthors may:\n- Deposit the published version in institutional repositories\n- Share through academic social networks\n- Include in books, monographs, or other publications\n- Post on personal or institutional websites\nRequirement: All additional distributions must maintain the CC BY 4.0 license and proper attribution.\n5. Self-Archiving and Pre-Print Sharing\nAuthors are encouraged to:\n- Share pre-prints and post-prints online\n- Deposit in subject-specific repositories (e.g., arXiv, bioRxiv)\n- Engage in scholarly communication throughout the publication process\n6. Open Access Commitment\nThis journal provides immediate open access to all content, supporting the global exchange of knowledge without financial, legal, or technical barriers.","source_license":"CC0","license_restricted":false}